Revenue (TTM) Chart

View Revenue (TTM) for POCI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (TTM) Chart
Start Trial

Historical Revenue (TTM) Data

View and export this data back to 1999. Start Trial.
Date Value
March 31, 2026 28.94M
December 31, 2025 24.42M
September 30, 2025 21.58M
June 30, 2025 19.09M
March 31, 2025 17.63M
December 31, 2024 18.68M
September 30, 2024 18.98M
June 30, 2024 19.10M
March 31, 2024 19.41M
December 31, 2023 19.22M
September 30, 2023 20.28M
June 30, 2023 21.04M
March 31, 2023 20.81M
December 31, 2022 20.42M
September 30, 2022 18.43M
June 30, 2022 15.68M
March 31, 2022 13.56M
December 31, 2021 11.36M
September 30, 2021 10.25M
June 30, 2021 10.67M
March 31, 2021 10.24M
December 31, 2020 10.16M
September 30, 2020 10.17M
June 30, 2020 9.923M
March 31, 2020 10.07M
Date Value
December 31, 2019 9.079M
September 30, 2019 7.760M
June 30, 2019 6.804M
March 31, 2019 5.885M
December 31, 2018 5.234M
September 30, 2018 4.569M
June 30, 2018 4.038M
March 31, 2018 3.297M
December 31, 2017 3.545M
September 30, 2017 3.334M
June 30, 2017 3.154M
March 31, 2017 3.397M
December 31, 2016 3.555M
September 30, 2016 3.908M
June 30, 2016 3.917M
March 31, 2016 3.917M
December 31, 2015 3.918M
September 30, 2015 3.940M
June 30, 2015 3.912M
March 31, 2015 3.852M
December 31, 2014 3.543M
September 30, 2014 3.574M
June 30, 2014 3.651M
March 31, 2014 3.551M
December 31, 2013 3.373M

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (TTM) Range, Past 5 Years

View Revenue (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (TTM) Benchmarks

View Revenue (TTM) Benchmarks
Start Trial
RxSight, Inc. 127.58M
Abbott Laboratories 46.58B
Align Technology, Inc. 4.140B
AngioDynamics, Inc. 320.17M
Accuray, Inc. 401.95M